Home > Balance Sheet > CIPLA

CIPLA
Total Non-Current Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹82 Cr₹184 Cr₹622 Cr₹1,660 Cr₹2,972 Cr

What is the latest Total Non-Current Liabilities ratio of CIPLA ?

The latest Total Non-Current Liabilities ratio of CIPLA is ₹82 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹82 Cr
Mar2023₹184 Cr
Mar2022₹622 Cr
Mar2021₹1,660 Cr
Mar2020₹2,972 Cr

How is Total Non-Current Liabilities of CIPLA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹82 Cr
-55.36
Mar2023 ₹184 Cr
-70.48
Mar2022 ₹622 Cr
-62.55
Mar2021 ₹1,660 Cr
-44.15
Mar2020 ₹2,972 Cr -

Compare Total Non-Current Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹121,324.6 Cr -0.1% 0.5% 1.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.4% -1.2% 12.2% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 2.6% 8.4% 48.5% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 3.2% 11.8% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,345.0 Cr 3.4% 0.5% 12.8% Stock Analytics
MANKIND PHARMA ₹98,512.2 Cr 1.4% -6.4% 11.8% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-0.1%

0.5%

1.7%

SENSEX

0.3%

0.7%

8.8%


You may also like the below Video Courses